Iceland· IS-EU/1/23/1716/005-006+011
Camzyos
A mavacamten product containing mavacamtenum inn, registered in Iceland by Bristol-Myers Squibb Pharma EEIG*. The same ATC class is registered in 15 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Mavacamten is registered in 15 of 19 countries.
Countries holding a registration under ATC C01EB24 (mavacamten), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 9 of them publish a price we can compare per daily dose
Mavacamten · ATC C01EB24
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mavacamten costs, country by country.
Normalised to the WHO defined daily dose (5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mavacamten · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$118.52
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Mavacamtenum INN
- Manufacturer
- Bristol-Myers Squibb Pharma EEIG*
- Country
- Iceland (IS)
- ATC code
- C01EB24
- ATC class
- Mavacamten
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean43569628 stk x1 þpakkiISK 263709
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mavacamten in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCAMZYOSBristol-Myers Squibb Pharma EEIG, Dublin
- CanadaCAMZYOSBRISTOL-MYERS SQUIBB CANADA
- SwitzerlandCamzyos
- SpainCAMZYOS 10 MG CAPSULAS DURASBristol-Myers Squibb Pharma Eeig
- FinlandCAMZYOSBristol-Myers Squibb Pharma EEIG
- FranceCAMZYOS 10 mg, géluleBRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
- United KingdomCamzyos 10mg capsulesBristol-Myers Squibb Pharmaceuticals Ltd
- IrelandCamzyos 10 mg Capsule hardBristol-Myers Squibb Pharma EEIG
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Camzyos
- Norway · Camzyos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3c35b70d-b86e-4ad9-a250-13b52c4e27a4 GET /v1/drugs/3c35b70d-b86e-4ad9-a250-13b52c4e27a4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Hart hylki",
"source": "lyfjastofnun",
"atc_raw": "C01EB24",
"marketed": true,
"strength": "10 mg",
"ma_number": "EU/1/23/1716/005-006+011",
"substance": "Mavacamtenum INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í hjartasjúkdómum.\r\nMarkaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "45103"
}See everything about mavacamten.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.